September 16, 2020
Webinars
Value-Based Care

Market Access Enablement Strategies, Part 1: Launching in a Virtual World

Summary

Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.

Access Recording

From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.

Key Topics

Pre-/post-launch planning
Third-party channel and distribution
Patient access strategy
Customer models and engagement

Don’t forget to register for Part 2 of our Market Access webinar series.

Panelists

Moderator

Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Speaker

Lance Grady , Executive Vice President, Life Sciences Strategy & Growth

Lance Grady is the head of Avalere’s Life Sciences Strategy & Growth.

Speaker

Omar Hafez , Practice Director, Market Access & Reimbursement

Omar advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning.

Speaker

Dana Macher

Dana Macher specializes in market access and commercialization.

Omar Hafez
Practice Director
Sarah Butler
Lance Grady
Dana Macher

From beginning to end, our team synergy
produces measurable results. Let's work together.